For: | Tan EH, Tan CH. Imaging of gastroenteropancreatic neuroendocrine tumors. World J Clin Oncol 2011; 2(1): 28-43 [PMID: 21603312 DOI: 10.5306/wjco.v2.i1.28] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v2/i1/28.htm |
Number | Citing Articles |
1 |
Marina Tsoli, Gregory Kaltsas. Encyclopedia of Endocrine Diseases. 2019; : 13 doi: 10.1016/B978-0-12-801238-3.65346-1
|
2 |
Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Elisabetta de Lutio di Castelguidone, Luigi Camera, Salvatore Tafuto, Antonio Avallone, Andrea Belli, Paola Incollingo, Raffaele Palaia, Francesco Izzo, Antonella Petrillo. The multidisciplinary team for gastroenteropancreatic neuroendocrine tumours: the radiologist’s challenge. Radiology and Oncology 2019; 53(4): 373 doi: 10.2478/raon-2019-0040
|
3 |
Ali Devrim Karaosmanoglu, Mehmet Ruhi Onur, Ronald S. Arellano. Textbook of Gastrointestinal Oncology. 2019; : 445 doi: 10.1007/978-3-030-18890-0_25
|
4 |
Ángela Sala Hernández, Eva María Montalvá Orón, Eugenia Pareja Ibars, Neus Ballester Pla, Rafael López Andújar. Management of pancreatic gastrinoma associated with Von Hippel-Lindau disease: a case report. Revista Española de Enfermedades Digestivas 2016; 109 doi: 10.17235/reed.2016.4224/2016
|
5 |
R. Arnold, P. Langer, Matthias Rothmund, G. Klöppel, P.H. Kann, J.T. Heverhagen, V. Fendrich, D.K. Bartsch, A. Rinke, X. Müller, K.J. Klose, W. Brenner, V. Prasad, B. Wiedenmann, H. Jann, T. Gress, A. Pascher, P. Neuhaus, N. Habbe, B. Simon, B. Stinner. Praxis der Viszeralchirurgie. 2013; : 497 doi: 10.1007/978-3-642-14285-7_5
|
6 |
Wei-Xia Li, Fei Miao, Xue-Qin Xu, Jing Zhang, Zhi-Yuan Wu, Ke-Min Chen, Fu-Hua Yan, Xiao-Zhu Lin. Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading. Academic Radiology 2021; 28(2): 208 doi: 10.1016/j.acra.2020.01.033
|
7 |
Jae Hyun Kim, Jeong Min Lee, Ji Hoon Park, Soo Chin Kim, Ijin Joo, Joon Koo Han, Byung Ihn Choi. Solid Pancreatic Lesions: Characterization by Using Timing Bolus Dynamic Contrast-enhanced MR Imaging Assessment—A Preliminary Study. Radiology 2013; 266(1): 185 doi: 10.1148/radiol.12120111
|
8 |
Azza A. Elgendy, William MacDonald, Joseph Whitnah, Daniel Malone, Brandon Johnson, Nadia Huq. Hindgut gastropancreatic neuroendocrine carcinoma mimicking hydatid disease. Radiology Case Reports 2018; 13(1): 186 doi: 10.1016/j.radcr.2017.10.027
|
9 |
Laetitia Garby, Philippe Caron, Francine Claustrat, Philippe Chanson, Antoine Tabarin, Vincent Rohmer, Gwenaëlle Arnault, Fabrice Bonnet, Olivier Chabre, Sophie Christin-Maitre, Hélène du-Boullay, Arnaud Murat, Ihab Nakib, Jean-Louis Sadoul, Geneviève Sassolas, Bruno Claustrat, Gérald Raverot, Françoise Borson-Chazot. Clinical Characteristics and Outcome of Acromegaly Induced by Ectopic Secretion of Growth Hormone-Releasing Hormone (GHRH): A French Nationwide Series of 21 Cases. The Journal of Clinical Endocrinology & Metabolism 2012; 97(6): 2093 doi: 10.1210/jc.2011-2930
|
10 |
J.N. Rosenbaum, Ricardo Vincent Lloyd. Pancreatic Neuroendocrine Neoplasms. Surgical Pathology Clinics 2014; 7(4): 559 doi: 10.1016/j.path.2014.08.005
|
11 |
E. Edmund Kim, Vanessa Murad, Jin-Chul Paeng, Hyung-Jun Im, Ji-Young Kim, Gi-Jeong Cheon. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. 2022; : 181 doi: 10.1007/978-3-030-92349-5_3
|
12 |
Karamvir Chandel, Anupam Lal, Rohit K. Srinivas, Debajyoti Chatterjee, Vikas Gupta. Gallbladder Neuroendocrine Carcinoma: A Case Report with Radiological–Pathological Correlation. Journal of Gastrointestinal and Abdominal Radiology 2022; 5(03): 191 doi: 10.1055/s-0042-1742676
|
13 |
Lisa Bodei, Anders Sundin, Mark Kidd, Vikas Prasad, Irvin M. Modlin. The Status of Neuroendocrine Tumor Imaging: From Darkness to Light?. Neuroendocrinology 2015; 101(1): 1 doi: 10.1159/000367850
|
14 |
Marta Zerunian, Davide Bellini, Andrea Laghi. Abdominal Neuroendocrine Tumors. Updates in Surgery 2018; : 91 doi: 10.1007/978-88-470-3955-1_7
|
15 |
S. O. Nikogosyan, M. N. Sekerskaya, T. S. Tagibova, O. A. Anurova. Clinical and morphological characteristics of ovarian neuroendocrine tumors. Tumors of female reproductive system 2019; 15(1): 58 doi: 10.17650/1994-4098-2019-15-1-58-66
|
16 |
Anshul Sharma, Chandan J. Das, Govind K. Makharia, Geetanjali Arora, Rakesh Kumar. Comparison of Contrast-Enhanced CT + CT Enterography and 68Ga-DOTANOC PET/CT in Gastroenteropancreatic Neuroendocrine Tumors. Clinical Nuclear Medicine 2020; 45(11): 848 doi: 10.1097/RLU.0000000000003188
|
17 |
Rajesh S. Shinde, Vikram A. Chaudhari, Manish S. Bhandare, Shailesh V. Shrikhande. Tata Memorial Centre Textbook of Oncology. 2024; : 611 doi: 10.1007/978-981-99-3378-5_43
|
18 |
Robert T. Jensen. Yamada' s Textbook of Gastroenterology. 2015; : 1078 doi: 10.1002/9781118512074.ch57
|
19 |
Marco De Martino, Simona Pellecchia, Francesco Esposito, Nadia Tosti, Cristina Quintavalle, Serenella Eppenberger-Castori, Vincenza Carafa, Alberto Righi, Paolo Chieffi, Alfredo Fusco, Luigi Maria Terracciano, Pierlorenzo Pallante. The role of HMGA1 protein in gastroenteropancreatic neuroendocrine tumors. Cell Cycle 2022; 21(12): 1335 doi: 10.1080/15384101.2022.2050646
|
20 |
Dushyant V. Sahani, Pietro A. Bonaffini, Carlos Fernández–Del Castillo, Michael A. Blake. Gastroenteropancreatic Neuroendocrine Tumors: Role of Imaging in Diagnosis and Management. Radiology 2013; 266(1): 38 doi: 10.1148/radiol.12112512
|
21 |
Marina Tsoli, Eleftherios Chatzellis, Anna Koumarianou, Dionysia Kolomodi, Gregory Kaltsas. Current best practice in the management of neuroendocrine tumors. Therapeutic Advances in Endocrinology and Metabolism 2019; 10 doi: 10.1177/2042018818804698
|
22 |
|
23 |
E. Edmund Kim, Hyung-Jun Im, Dong Soo Lee, Keon Wook Kang. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT. 2016; : 443 doi: 10.1007/978-3-319-28652-5_3
|
24 |
Dushyant V. Sahani, Pietro A. Bonaffini, Onofrio A. Catalano, Alexander R. Guimaraes, Michael A. Blake. State-of-the-Art PET/CT of the Pancreas: Current Role and Emerging Indications. RadioGraphics 2012; 32(4): 1133 doi: 10.1148/rg.324115143
|
25 |
Hulya Wieshmann, K. N. Pannag Desai. Textbook of Pancreatic Cancer. 2021; : 549 doi: 10.1007/978-3-030-53786-9_36
|
26 |
F. Kulali, A. Semiz-Oysu, M. Demir, M. Segmen-Yilmaz, Y. Bukte. Role of diffusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors. Diagnostic and Interventional Imaging 2018; 99(5): 301 doi: 10.1016/j.diii.2017.10.012
|
27 |
|
28 |
Dorota Pach, Anna Sowa-Staszczak, Jolanta Kunikowska, Leszek Królicki, Małgorzata Trofimiuk, Agnieszka Stefańska, Monika Tomaszuk, Bogusław Głowa, Renata Mikołajczak, Dariusz Pawlak, Agata Jabrocka-Hybel, Alicja B. Hubalewska-Dydejczyk. Repeated cycles of peptide receptor radionuclide therapy (PRRT) – Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET. Radiotherapy and Oncology 2012; 102(1): 45 doi: 10.1016/j.radonc.2011.08.006
|
29 |
K. Hickman, T.J. Sadler, T.T. Zhang, E. Boninsegna, V. Majcher, E. Godfrey. Pancreatic cystic lesions and the role of contrast enhanced endoscopic ultrasound. Clinical Radiology 2022; 77(6): 418 doi: 10.1016/j.crad.2022.02.017
|
30 |
Valentina Ciaravino, Riccardo De Robertis, Paolo Tinazzi Martini, Nicolò Cardobi, Sara Cingarlini, Antonio Amodio, Luca Landoni, Paola Capelli, Mirko D’Onofrio. Imaging presentation of pancreatic neuroendocrine neoplasms. Insights into Imaging 2018; 9(6): 943 doi: 10.1007/s13244-018-0658-6
|
31 |
Kohei Hanaoka, Noriaki Miyaji, Hiroto Yoneyama, Matsuyoshi Ogawa, Takamasa Maeda, Kenta Sakaguchi, Takashi Iimori, Hiroyuki Tsushima. Radiological Technology for Targeted Radionuclide Therapy. Japanese Journal of Radiological Technology 2020; 76(12): 1237 doi: 10.6009/jjrt.2020_JSRT_76.12.1237
|
32 |
Fabio Pellegrino, Vincenza Granata, Roberta Fusco, Francesca Grassi, Salvatore Tafuto, Luca Perrucci, Giulia Tralli, Mariano Scaglione. Diagnostic Management of Gastroenteropancreatic Neuroendocrine Neoplasms: Technique Optimization and Tips and Tricks for Radiologists. Tomography 2023; 9(1): 217 doi: 10.3390/tomography9010018
|
33 |
Ron Basuroy, Raj Srirajaskanthan, John K. Ramage. Neuroendocrine Tumors. Gastroenterology Clinics of North America 2016; 45(3): 487 doi: 10.1016/j.gtc.2016.04.007
|
34 |
Ananda Kumar Kanduluru, Madduri Srinivasarao, Charity Wayua, Philip S. Low. Evaluation of a Neurokinin-1 Receptor–Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging. Molecular Imaging and Biology 2020; 22(2): 377 doi: 10.1007/s11307-019-01391-w
|
35 |
K. A. Romanova, A. B. Lukianchenko, B. M. Medvedeva, A. N. Polyakov. Concomitant intraductal papillary mucinous neoplasm (IPMN) and neuroendocrine tumor (NET) of pancreas. Medical Visualization 2021; 25(3): 43 doi: 10.24835/1607-0763-1030
|
36 |
Ameya Puranik, Sonal Prasad, Indraja D. Devi, Vikas Prasad. Radiology‐Nuclear Medicine Diagnostic Imaging. 2023; : 512 doi: 10.1002/9781119603627.ch17
|
37 |
Naoya Kimura, Masatsugu Hiraki, Hiroki Koga, Michiaki Akashi, Naohiko Kohya, Ryuichiro Samejima. Primary Neuroendocrine Neoplasm of the Anterior Sacral Region Treated by Laparoscopic Resection. The Japanese Journal of Gastroenterological Surgery 2023; 56(1): 42 doi: 10.5833/jjgs.2021.0151
|
38 |
Thomas A. Hope, Miguel Hernandez Pampaloni, Robert R. Flavell, Eric K. Nakakura, Emily K. Bergsland. Somatostatin receptor PET/MRI for the evaluation of neuroendocrine tumors. Clinical and Translational Imaging 2017; 5(1): 63 doi: 10.1007/s40336-016-0193-8
|
39 |
Steven D. Colquhoun. Neuroendocrine tumors with hepatic metastases: A review of evolving treatment options. Liver Research 2018; 2(2): 92 doi: 10.1016/j.livres.2018.08.002
|
40 |
Ruo-Kun Li, Jing Zhao, Sheng-Xiang Rao, Cai-Zhong Chen, Meng-Su Zeng, Jin-Wei Qiang. Primary hepatic neuroendocrine carcinoma: MR imaging findings including preliminary observation on diffusion-weighted imaging. Abdominal Imaging 2013; 38(6): 1269 doi: 10.1007/s00261-013-0029-1
|
41 |
Samuel J. Galgano, Benjamin Wei, J. Bart Rose. PET Imaging of Neuroendocrine Tumors. Radiologic Clinics of North America 2021; 59(5): 789 doi: 10.1016/j.rcl.2021.05.006
|
42 |
Mark Masciocchi. Pancreatic Imaging. Endocrinology and Metabolism Clinics of North America 2017; 46(3): 761 doi: 10.1016/j.ecl.2017.04.006
|
43 |
Anupama Ramachandran, Kumble Seetharama Madhusudhan. Advances in the imaging of gastroenteropancreatic neuroendocrine neoplasms. World Journal of Gastroenterology 2022; 28(26): 3008-3026 doi: 10.3748/wjg.v28.i26.3008
|
44 |
M. Tsoli, H. Wilson, P. Armonis, L. Kamieniarz, J. Thuringer, R. Mirnezami, M. Caplin, G. Kaltsas, C. Toumpanakis. Peritoneal metastases in patients with neuroendocrine neoplasms: a challenging site of metastases with clinical and prognostic implications. Journal of Endocrinological Investigation 2024; 47(9): 2295 doi: 10.1007/s40618-024-02330-5
|
45 |
Rachel Jorge D Cossetti, Regis Otaviano França Bezerra, Brenda Gumz, Adriana Telles, Frederico P Costa. Whole body diffusion for metastatic disease assessment in neuroendocrine carcinomas: comparison with OctreoScan® in two cases. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-82
|
46 |
Stacey A. Milan, Charles J. Yeo. Neuroendocrine tumors of the pancreas. Current Opinion in Oncology 2012; 24(1): 46 doi: 10.1097/CCO.0b013e32834c554d
|
47 |
Ahmed Fathala, Mohammed H. Al Qahtani, Moheieldin M. Abouzied. Molecular imaging of a glucagonoma with 18F-FDG PET/CT and 68Ga-DOTATATE PET/CT imaging: A case report and review of the literature. Radiology Case Reports 2020; 15(1): 19 doi: 10.1016/j.radcr.2019.10.007
|
48 |
Samuel J. Galgano, Kedar Sharbidre, Desiree E. Morgan. Multimodality Imaging of Neuroendocrine Tumors. Radiologic Clinics of North America 2020; 58(6): 1147 doi: 10.1016/j.rcl.2020.07.008
|
49 |
Ameya D. Puranik, Archi Agrawal, Sneha Shah, Nilendu Purandare, Venkatesh Rangarajan. PET/CT in Hepatobiliary and Pancreatic Malignancies. 2018; : 65 doi: 10.1007/978-3-319-60507-4_7
|
50 |
|
51 |
James R. Marak, Tushant Kumar, Shivam Dwivedi, Rohini Khurana. Neuroendocrine tumor of the gall bladder: A rare case report with review of literature. Radiology Case Reports 2023; 18(11): 3912 doi: 10.1016/j.radcr.2023.08.015
|
52 |
Giovanna Pepe, Giovanni Matassa, Francesca Piccoli, Arturo Chiti. Neuroendocrine Neoplasia Management. 2021; : 75 doi: 10.1007/978-3-030-72830-4_6
|
53 |
Praveen Jayapal, Ali Rashidi, Lucia Baratto, Sheri Spunt, Heike Daldrup-Link. Clinical PET/MRI. 2023; : 139 doi: 10.1016/B978-0-323-88537-9.00010-6
|
54 |
Claire K. Mulvey, Katherine Van Loon, Emily K. Bergsland, Umesh Masharani, Eric K. Nakakura. Complicated Case Presentation. Pancreas 2017; 46(3): 416 doi: 10.1097/MPA.0000000000000770
|
55 |
Hwajin Cha, Jiyoung Hwang, Seong Sook Hong, Eun Ji Lee, Hyun-joo Kim, Yun-Woo Chang. Mesenteric Lesions with Similar or Distinctive Appearances on CT. Journal of the Korean Society of Radiology 2019; 80(6): 1091 doi: 10.3348/jksr.2019.80.6.1091
|
56 |
S Singh, A Khurana, P Kaur, AK Chauhan, R Sen. Small Cell Neuroendocrine Tumor of Base of Tongue - Treatment Strategies of A Rare Entity. Journal of Oral Health and Community Dentistry 2014; 8(3): 181 doi: 10.5005/johcd-8-3-181
|
57 |
Fangqing Wang, Jinjin Wang, Ye Li, Xiao Wang, Dexin Yu, XiaoMing Zhang. Correlation of four-phase CT findings of rectal neuroendocrine neoplasms with different World Health Organization grades. Abdominal Radiology 2022; doi: 10.1007/s00261-022-03771-3
|
58 |
Jennifer R. Eads, Neal J. Meropol. A New Era for the Systemic Therapy of Neuroendocrine Tumors. The Oncologist 2012; 17(3): 326 doi: 10.1634/theoncologist.2011-0356
|
59 |
Anna Sowa-Staszczak, Robert Chrzan, Dorota Pach, Agnieszka Stefańska, Monika Tomaszuk, Monika Buziak-Bereza, Maciej Kołodziej, Elwira Przybylik-Mazurek, Alicja Hubalewska-Dydejczyk. Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors?. Clinical Imaging 2012; 36(4): 360 doi: 10.1016/j.clinimag.2011.11.005
|
60 |
Oguz Koc, Yigit Duzkoylu, Yavuz Selim Sari, Hasan Bektas, Gungor Uzum, Vahit Tunali, Esra Pasaoglu. Duodenal somatostatinoma: a case report and review of the literature. Journal of Medical Case Reports 2013; 7(1) doi: 10.1186/1752-1947-7-115
|
61 |
Amir Houshang Mohammad Alizadeh, Baran Parhizkar, Hassan Rajabalinia. The Value of Endoscopic Ultrasound in a 47-Year-Old Man with Cystic Lesions of the Liver and Pancreas. Case Reports in Gastroenterology 2014; 8(1): 141 doi: 10.1159/000362439
|
62 |
Diego Ferone, Elena Nazzari, Federica Grillo, Stefania Sciallero, Silvia Morbelli, Franco De Cian, Giuseppe Cittadini, Manuela Albertelli, Giannini Edoardo. Atlas of Thyroid and Neuroendocrine Tumor Markers. 2018; : 203 doi: 10.1007/978-3-319-62506-5_14
|
63 |
Dainik Patel, David Chan, Gabrielle Cehic, Nick Pavlakis, Timothy Jay Price. Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Review of Endocrinology & Metabolism 2016; : 1 doi: 10.1080/17446651.2016.1199952
|
64 |
Anna Gallotti, Rocio Perez Johnston, Pietro A. Bonaffini, Thun Ingkakul, Vikram Deshpande, Carlos Fernández-del Castillo, Dushyant V. Sahani. Incidental Neuroendocrine Tumors of the Pancreas: MDCT Findings and Features of Malignancy. American Journal of Roentgenology 2013; 200(2): 355 doi: 10.2214/AJR.11.8037
|
65 |
Marina Tsoli, Kosmas Daskalakis, Maria Wedin, Anna Angelousi, Sebastian Povlsen, Raj Srirajaskanthan, George Giovos, Martin O. Weickert, Angelika Kogut, Beata Kos‐Kudla, Kira Oleinikov, Simona Grozinsky‐Glasberg, Gregory Kaltsas. Pancreatic metastases in patients with neuroendocrine neoplasms: A multi‐centre cohort study. Journal of Neuroendocrinology 2023; 35(4) doi: 10.1111/jne.13269
|
66 |
KAI XIN, JIA WEI, HAO WANG, WENXIAN GUAN, BAORUI LIU. Neoadjuvant chemotherapy followed by D2 gastrectomy and esophagojejunal Roux-en-Y anastomosis in gastric small cell carcinoma: A case report. Oncology Letters 2014; 8(6): 2549 doi: 10.3892/ol.2014.2557
|